Generic Injectables Market Report

Global and Region Generic Injectables Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：138
  • REPORT CODE：GMM949489
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Generic Injectables market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Generic Injectablesmarket, defines the market attractiveness level of Generic Injectables market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Generic Injectables industry, describes the types of Generic Injectables market, the applications of major players and the market size, and deeply analyzes the current situation of the global Generic Injectables market and the development prospects and opportunities of Generic Injectables industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Generic Injectables market in Chapter 13.

    By Player:

    • Biocon

    • Teva Pharmaceutical

    • Lupin Pharmaceuticals

    • Baxter

    • Sanofi

    • Mylan

    • Sandoz International

    • Hikma Pharmaceuticals

    • Pfizer

    • Fresenius

    By Type:

    • Large Molecule Injectables (Biosimilars)

    • Small Molecule Injectables

    By End-User:

    • Oncology

    • Infectious Diseases

    • Cardiology

    • Diabetes

    • Immunology

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Generic Injectables Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Generic Injectables Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Generic Injectables Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Generic Injectables Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Generic Injectables Market Analysis and Outlook to 2022

    • 7.1 Global Generic Injectables Consumption (2017-2022)

    • 7.2 United States Generic Injectables Consumption (2017-2022)

    • 7.3 Europe Generic Injectables Consumption (2017-2022)

    • 7.4 China Generic Injectables Consumption (2017-2022)

    • 7.5 Japan Generic Injectables Consumption (2017-2022)

    • 7.6 India Generic Injectables Consumption (2017-2022)

    • 7.7 South Korea Generic Injectables Consumption (2017-2022)

    8 Region and Country-wise Generic Injectables Market Analysis and Outlook to 2028

    • 8.1 Global Generic Injectables Consumption Forecast (2022-2028)

    • 8.2 United States Generic Injectables Consumption Forecast (2022-2028)

    • 8.3 Europe Generic Injectables Consumption Forecast (2022-2028)

    • 8.4 China Generic Injectables Consumption Forecast (2022-2028)

    • 8.5 Japan Generic Injectables Consumption Forecast (2022-2028)

    • 8.6 India Generic Injectables Consumption Forecast (2022-2028)

    • 8.7 South Korea Generic Injectables Consumption Forecast (2022-2028)

    9 Global Generic Injectables Market Outlook by Types and Applications to 2022

    • 9.1 Global Generic Injectables Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Large Molecule Injectables (Biosimilars) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Small Molecule Injectables Consumption and Growth Rate (2017-2022)

    • 9.2 Global Generic Injectables Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Immunology Consumption and Growth Rate (2017-2022)

    10 Global Generic Injectables Market Outlook by Types and Applications to 2028

    • 10.1 Global Generic Injectables Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Large Molecule Injectables (Biosimilars) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Small Molecule Injectables Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Generic Injectables Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Immunology Consumption Forecast and Growth Rate (2022-2028)

    11 Global Generic Injectables Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Generic Injectables Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Generic Injectables Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Generic Injectables Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Generic Injectables Market Competitive Analysis

    • 14.1 Biocon

      • 14.1.1 Biocon Company Details

      • 14.1.2 Biocon Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biocon Generic Injectables Product and Service

    • 14.2 Teva Pharmaceutical

      • 14.2.1 Teva Pharmaceutical Company Details

      • 14.2.2 Teva Pharmaceutical Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Teva Pharmaceutical Generic Injectables Product and Service

    • 14.3 Lupin Pharmaceuticals

      • 14.3.1 Lupin Pharmaceuticals Company Details

      • 14.3.2 Lupin Pharmaceuticals Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Lupin Pharmaceuticals Generic Injectables Product and Service

    • 14.4 Baxter

      • 14.4.1 Baxter Company Details

      • 14.4.2 Baxter Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Baxter Generic Injectables Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Generic Injectables Product and Service

    • 14.6 Mylan

      • 14.6.1 Mylan Company Details

      • 14.6.2 Mylan Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mylan Generic Injectables Product and Service

    • 14.7 Sandoz International

      • 14.7.1 Sandoz International Company Details

      • 14.7.2 Sandoz International Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sandoz International Generic Injectables Product and Service

    • 14.8 Hikma Pharmaceuticals

      • 14.8.1 Hikma Pharmaceuticals Company Details

      • 14.8.2 Hikma Pharmaceuticals Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Hikma Pharmaceuticals Generic Injectables Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Generic Injectables Product and Service

    • 14.10 Fresenius

      • 14.10.1 Fresenius Company Details

      • 14.10.2 Fresenius Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Fresenius Generic Injectables Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Generic Injectables

    • Figure Generic Injectables Picture

    • Table Global Generic Injectables Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Injectables Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Injectables Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Generic Injectables Consumption by Country (2017-2022)

    • Figure United States Generic Injectables Consumption and Growth Rate (2017-2022)

    • Table Europe Generic Injectables Consumption and Growth Rate (2017-2022)

    • Figure China Generic Injectables Consumption and Growth Rate (2017-2022)

    • Figure Japan Generic Injectables Consumption and Growth Rate (2017-2022)

    • Figure India Generic Injectables Consumption and Growth Rate (2017-2022)

    • Figure South Korea Generic Injectables Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Injectables Consumption Forecast by Country (2022-2028)

    • Figure United States Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Generic Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Molecule Injectables (Biosimilars) Consumption and Growth Rate (2017-2022)

    • Figure Global Small Molecule Injectables Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Immunology Consumption and Growth Rate (2017-2022)

    • Figure Global Large Molecule Injectables (Biosimilars) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small Molecule Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Generic Injectables Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Generic Injectables Export by Region (Top 5 Countries) (2017-2028)

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Generic Injectables Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Generic Injectables Product and Service

    • Table Lupin Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Lupin Pharmaceuticals Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Pharmaceuticals Generic Injectables Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Generic Injectables Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Generic Injectables Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Generic Injectables Product and Service

    • Table Sandoz International (Foundation Year, Company Profile and etc.)

    • Table Sandoz International Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International Generic Injectables Product and Service

    • Table Hikma Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Hikma Pharmaceuticals Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Pharmaceuticals Generic Injectables Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Generic Injectables Product and Service

    • Table Fresenius (Foundation Year, Company Profile and etc.)

    • Table Fresenius Generic Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Generic Injectables Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US